Iron showdown: pills vs. IV for anemic toddlers
NCT ID NCT07657091
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial compares two ways to treat iron deficiency anemia in children aged 1 to 5 years: oral iron syrup taken daily for weeks, or a single intravenous (IV) iron infusion. The goal is to see which approach raises hemoglobin levels faster and with fewer side effects. The study includes 100 children with moderate anemia, excluding those with severe cases or other blood disorders.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- iron (ferrous sulfate or iron sucrose)
- What this could lead to
- If IV iron proves more effective, it could offer a faster, better-tolerated treatment option for young children with iron deficiency anemia.
- What could go wrong
- This is a small, early-phase trial (100 children), so results may not apply broadly. IV iron carries risks like allergic reactions, and oral iron often causes side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRON DEFICIENCY ANEMIA IN CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kharadar General Hospital
Karachi, Sindh, Pakistan